Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

MEDI vs SCHLX overlap: 44% of top holdings shared

Bottom line

How much do MEDI and SCHLX overlap?

44% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 47.2% of MEDI's assets and 46.5% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

MEDISCHLX
Weight overlap (top 25)44%
Shared holdings12
Weight in shared holdings47.2%46.5%
Total positions4465
Expense ratio0.8%1.06%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings MEDI and SCHLX have in common

Holding% of MEDI% of SCHLXOverlap
Eli Lilly & Co20.78%13.85%13.85%
Gilead Sciences Inc5.10%2.78%2.78%
AbbVie Inc3.09%4.90%3.09%
Intuitive Surgical Inc2.83%2.69%2.69%
Cencora Inc2.75%1.26%1.26%
Merck & Co Inc2.47%4.85%2.47%
Boston Scientific Corp2.40%2.10%2.10%
McKesson Corp2.02%2.05%2.02%
Danaher Corp1.73%2.13%1.73%
Novo Nordisk A/S1.46%1.73%1.46%
UnitedHealth Group Inc1.39%5.73%1.39%
Vertex Pharmaceuticals Inc1.22%2.45%1.22%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in MEDI

  1. Ascendis Pharma A/S — 13.61%
  2. Rhythm Pharmaceuticals Inc — 4.02%
  3. Revolution Medicines Inc — 2.54%
  4. Insmed Inc — 2.52%
  5. Natera Inc — 2.26%
  6. Abivax SA — 2.16%
  7. Insulet Corp — 2.10%
  8. Argenx SE — 2.07%
  9. Vaxcyte Inc — 2.06%
  10. Legend Biotech Corp — 1.91%
  11. Guardant Health Inc — 1.54%
  12. IDEXX Laboratories Inc — 1.40%
  13. PTC Therapeutics Inc — 1.31%

Only in SCHLX

  1. Johnson & Johnson — 6.19%
  2. AstraZeneca PLC — 3.80%
  3. Thermo Fisher Scientific Inc — 3.46%
  4. Novartis AG — 2.90%
  5. Amgen Inc — 2.88%
  6. Stryker Corp — 2.61%
  7. Abbott Laboratories — 2.39%
  8. Medtronic PLC — 1.54%
  9. Bristol-Myers Squibb Co — 1.50%
  10. Regeneron Pharmaceuticals Inc — 1.43%
  11. Cardinal Health Inc — 1.34%
  12. Roche Holding AG — 1.24%
  13. Pfizer Inc — 1.17%

Asset mix

Asset typeMEDISCHLX
Stocks99.6%99.6%
Cash & short-term funds—0.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryMEDISCHLX
US76.7%85.7%
DK15.1%1.7%
CH0.3%5.2%
GB—3.8%
NL2.6%1.0%
FR2.5%1.0%
KY1.9%—
IE—1.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do MEDI and SCHLX overlap?
About 44% by weight. 12 securities appear in both funds' top 25 holdings; they make up 47.2% of MEDI's assets and 46.5% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do MEDI and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co, AbbVie Inc, Gilead Sciences Inc, Intuitive Surgical Inc, Merck & Co Inc.
Should I own both MEDI and SCHLX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, MEDI or SCHLX?
SCHLX is broader, with 65 positions versus 44 for MEDI. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.